7-128846396-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001458.5(FLNC):c.4060C>T(p.Arg1354*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R1354R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001458.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics, G2P
- myofibrillar myopathy 5Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P
- hypertrophic cardiomyopathy 26Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- distal myopathy with posterior leg and anterior hand involvementInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- familial isolated restrictive cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- heart conduction diseaseInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FLNC | ENST00000325888.13 | c.4060C>T | p.Arg1354* | stop_gained | Exon 23 of 48 | 1 | NM_001458.5 | ENSP00000327145.8 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458232Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 725610 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 26 Pathogenic:1
Heterozygous variant NM_001458.5:c.4060C>T (p.Arg1354*) in the FLNC gene was found on WES data in male proband (43 y.o., Caucasian) with cardiomyopathy. The NM_001458.5:c.4060C>T (p.Arg1354Ter) variant is in The Genome Aggregation Database (gnomAD) v4.1.0 with total MAF 6.209e-7 (Date of access 15-07-2024). Clinvar contains an entry for this variant (Variation ID: 70588). This variant has been reported in an individual affected with dilated cardiomyopathy (PMID: 28436997). Loss-of-function variants in FLNC are known to be pathogenic (PMID: 27908349). In accordance with ACMG (2015) and Variant Interpretation for Dilated Cardiomyopathy (2020) (doi:10.1161/CIRCGEN.119.002480) criteria this variant is classified as Likely Pathogenic with following criteria selected: PM2, PVS1_strong. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32112656, 28436997) -
Cardiovascular phenotype Pathogenic:1
The p.R1354* pathogenic mutation (also known as c.4060C>T), located in coding exon 23 of the FLNC gene, results from a C to T substitution at nucleotide position 4060. This changes the amino acid from an arginine to a stop codon within coding exon 23. This mutation was reported in an individual with familial dilated cardiomyopathy (Janin A et al. Clin Genet, 2017 Dec;92:616-623). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg1354*) in the FLNC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLNC are known to be pathogenic (PMID: 27908349). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with FLNC-related conditions (PMID: 28436997). ClinVar contains an entry for this variant (Variation ID: 70588). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at